We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that, effective immediately, Brian M. Culley, previously the Company's Chief Business...
SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Odysseas D. Kostas, M.D. will join its Board of Directors. Dr. Kostas also will...
SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...
SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its Series E...
SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...
SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has signed agreements to purchase shares of its Series E convertible preferred...
SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug...
SAN DIEGO, Dec. 9 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present to...
South Korean Partner Demonstrates Bioequivalence and Similar Toxicity Profile to Taxotere SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today...
SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and nine months ended September 30, 2009. "Our third...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.003 | 30 | 0.01 | 0.014 | 0.009 | 1449147 | 0.01045807 | DE |
4 | 0.002 | 18.1818181818 | 0.011 | 0.014 | 0.009 | 1213114 | 0.01046113 | DE |
12 | -0.009 | -40.9090909091 | 0.022 | 0.024 | 0.009 | 2262571 | 0.01282786 | DE |
26 | -0.019 | -59.375 | 0.032 | 0.033 | 0.009 | 1945952 | 0.01765152 | DE |
52 | -0.017 | -56.6666666667 | 0.03 | 0.067 | 0.009 | 2411390 | 0.0307303 | DE |
156 | -0.07 | -84.3373493976 | 0.083 | 0.15 | 0.009 | 1255680 | 0.04615939 | DE |
260 | -0.022 | -62.8571428571 | 0.035 | 0.15 | 0.009 | 1628401 | 0.05789742 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions